ESTRO Multidisciplinary Management of Breast Cancer 2017

Previous Page

Next Page

Page Background

SLNs detected and removed

99.1%

60.8%

80.1%

SLNB prior to

any therapy

Re-SLNB after

SLNB + NACT

1013/1022

474/592

219/360

Arm A + B

Arm B

Arm C

50

P < 0.001

P < 0.001

P < 0.001

SLNB after NACT

for cN1 ycN0

Kuehn et al. Lancet Oncol 2013;14:609-18